164 related articles for article (PubMed ID: 9553721)
1. Retrovirus-mediated DNA repair gene transfer into xeroderma pigmentosum cells: perspectives for a gene therapy.
Zeng L; Sarasin A; Mezzina M
Cell Biol Toxicol; 1998 Mar; 14(2):105-10. PubMed ID: 9553721
[TBL] [Abstract][Full Text] [Related]
2. Functional lentiviral vectors for xeroderma pigmentosum gene therapy.
Marchetto MC; Correa RG; Menck CF; Muotri AR
J Biotechnol; 2006 Dec; 126(4):424-30. PubMed ID: 16857285
[TBL] [Abstract][Full Text] [Related]
3. Complementation of the DNA repair deficiency in human xeroderma pigmentosum group a and C cells by recombinant adenovirus-mediated gene transfer.
Muotri AR; Marchetto MC; Zerbini LF; Libermann TA; Ventura AM; Sarasin A; Menck CF
Hum Gene Ther; 2002 Oct; 13(15):1833-44. PubMed ID: 12396616
[TBL] [Abstract][Full Text] [Related]
4. Functional retroviral vector for gene therapy of xeroderma pigmentosum group D patients.
Carreau M; Quilliet X; Eveno E; Salvetti A; Danos O; Heard JM; Mezzina M; Sarasin A
Hum Gene Ther; 1995 Oct; 6(10):1307-15. PubMed ID: 8590735
[TBL] [Abstract][Full Text] [Related]
5. Retroviral-mediated correction of DNA repair defect in xeroderma pigmentosum cells is associated with recovery of catalase activity.
Quilliet X; Chevallier-Lagente O; Zeng L; Calvayrac R; Mezzina M; Sarasin A; Vuillaume M
Mutat Res; 1997 Dec; 385(3):235-42. PubMed ID: 9506892
[TBL] [Abstract][Full Text] [Related]
6. Cells from XP-D and XP-D-CS patients exhibit equally inefficient repair of UV-induced damage in transcribed genes but different capacity to recover UV-inhibited transcription.
van Hoffen A; Kalle WH; de Jong-Versteeg A; Lehmann AR; van Zeeland AA; Mullenders LH
Nucleic Acids Res; 1999 Jul; 27(14):2898-904. PubMed ID: 10390531
[TBL] [Abstract][Full Text] [Related]
7. Xeroderma pigmentosum: from genetics to hopes and realities of cutaneous gene therapy.
Magnaldo T
Expert Opin Biol Ther; 2004 Feb; 4(2):169-79. PubMed ID: 14998776
[TBL] [Abstract][Full Text] [Related]
8. Retrovirus-mediated gene transfer corrects DNA repair defect of xeroderma pigmentosum cells of complementation groups A, B and C.
Zeng L; Quilliet X; Chevallier-Lagente O; Eveno E; Sarasin A; Mezzina M
Gene Ther; 1997 Oct; 4(10):1077-84. PubMed ID: 9415314
[TBL] [Abstract][Full Text] [Related]
9. Xeroderma pigmentosum: from symptoms and genetics to gene-based skin therapy.
Magnaldo T; Sarasin A
Cells Tissues Organs; 2004; 177(3):189-98. PubMed ID: 15388993
[TBL] [Abstract][Full Text] [Related]
10. Comparative study of nucleotide excision repair defects between XPD-mutated fibroblasts derived from trichothiodystrophy and xeroderma pigmentosum patients.
Nishiwaki T; Kobayashi N; Iwamoto T; Yamamoto A; Sugiura S; Liu YC; Sarasin A; Okahashi Y; Hirano M; Ueno S; Mori T
DNA Repair (Amst); 2008 Dec; 7(12):1990-8. PubMed ID: 18817897
[TBL] [Abstract][Full Text] [Related]
11. Mouse model for the DNA repair/basal transcription disorder trichothiodystrophy reveals cancer predisposition.
de Boer J; van Steeg H; Berg RJ; Garssen J; de Wit J; van Oostrum CT; Beems RB; van der Horst GT; van Kreijl CF; de Gruijl FR; Bootsma D; Hoeijmakers JH; Weeda G
Cancer Res; 1999 Jul; 59(14):3489-94. PubMed ID: 10416615
[TBL] [Abstract][Full Text] [Related]
12. DNA repair-deficient Xpa and Xpa/p53+/- knock-out mice: nature of the models.
van Steeg H; de Vries A; van Oostrom CTh ; van Benthem J; Beems RB; van Kreijl CF
Toxicol Pathol; 2001; 29 Suppl():109-16. PubMed ID: 11695546
[TBL] [Abstract][Full Text] [Related]
13. Correction by the ERCC2 gene of UV sensitivity and repair deficiency phenotype in a subset of trichothiodystrophy cells.
Mezzina M; Eveno E; Chevallier-Lagente O; Benoit A; Carreau M; Vermeulen W; Hoeijmakers JH; Stefanini M; Lehmann AR; Weber CA
Carcinogenesis; 1994 Aug; 15(8):1493-8. PubMed ID: 8055625
[TBL] [Abstract][Full Text] [Related]
14. Xeroderma pigmentosum: a glimpse into nucleotide excision repair, genetic instability, and cancer.
Dworaczek H; Xiao W
Crit Rev Oncog; 2007 Nov; 13(2):159-77. PubMed ID: 18197791
[TBL] [Abstract][Full Text] [Related]
15. Cockayne syndrome complementation group B associated with xeroderma pigmentosum phenotype.
Itoh T; Cleaver JE; Yamaizumi M
Hum Genet; 1996 Feb; 97(2):176-9. PubMed ID: 8566949
[TBL] [Abstract][Full Text] [Related]
16. Spotlight on 'xeroderma pigmentosum'.
Fassihi H
Photochem Photobiol Sci; 2013 Jan; 12(1):78-84. PubMed ID: 23132518
[TBL] [Abstract][Full Text] [Related]
17. The cancer-free phenotype in trichothiodystrophy is unrelated to its repair defect.
Berneburg M; Clingen PH; Harcourt SA; Lowe JE; Taylor EM; Green MH; Krutmann J; Arlett CF; Lehmann AR
Cancer Res; 2000 Jan; 60(2):431-8. PubMed ID: 10667598
[TBL] [Abstract][Full Text] [Related]
18. Xeroderma pigmentosum genes: functions inside and outside DNA repair.
Sugasawa K
Carcinogenesis; 2008 Mar; 29(3):455-65. PubMed ID: 18174245
[TBL] [Abstract][Full Text] [Related]
19. Exploring DNA damage responses in human cells with recombinant adenoviral vectors.
Armelini MG; Lima-Bessa KM; Marchetto MC; Muotri AR; Chiganças V; Leite RA; Carvalho H; Menck CF
Hum Exp Toxicol; 2007 Nov; 26(11):899-906. PubMed ID: 18042584
[TBL] [Abstract][Full Text] [Related]
20. Development of a new easy complementation assay for DNA repair deficient human syndromes using cloned repair genes.
Carreau M; Eveno E; Quilliet X; Chevalier-Lagente O; Benoit A; Tanganelli B; Stefanini M; Vermeulen W; Hoeijmakers JH; Sarasin A
Carcinogenesis; 1995 May; 16(5):1003-9. PubMed ID: 7767957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]